ICARIA-MM study: efficacy analysis according to prior lines of treatment
dc.contributor.author | Bringhen, Sara | |
dc.contributor.author | Attal, Michel | |
dc.contributor.author | Pour, Ludek | |
dc.contributor.author | Vorobyev, Vladimir | |
dc.contributor.author | Vural, Filiz | |
dc.contributor.author | Warzocha, Krzysztof | |
dc.contributor.author | Richardson, Paul G. | |
dc.date.accessioned | 2020-12-01T12:09:12Z | |
dc.date.available | 2020-12-01T12:09:12Z | |
dc.date.issued | 2019 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.identifier.doi | 10.1016/j.clml.2019.09.407 | |
dc.identifier.endpage | E246 | en_US |
dc.identifier.issn | 2152-2650 | |
dc.identifier.issn | 2152-2669 | |
dc.identifier.issue | 10 | en_US |
dc.identifier.startpage | E245 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.clml.2019.09.407 | |
dc.identifier.uri | https://hdl.handle.net/11454/63357 | |
dc.identifier.volume | 19 | en_US |
dc.identifier.wos | WOS:000491229800404 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Cig Media Group, Lp | en_US |
dc.relation.ispartof | Clinical Lymphoma Myeloma & Leukemia | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | CD38 | en_US |
dc.subject | Multiple myeloma | en_US |
dc.subject | Relapsed/Refractory | en_US |
dc.title | ICARIA-MM study: efficacy analysis according to prior lines of treatment | en_US |
dc.type | Conference Object | en_US |